Digestives & Intestinal Remedies - Japan

  • Japan
  • In Japan, the revenue generated in the Digestives & Intestinal Remedies market market in 2024 amounts to US$0.94bn.
  • It is projected that the market will experience an annual growth rate of 2.43% from 2024 to 2029 (CAGR 2024-2029).
  • When compared globally, in China leads the pack with a revenue of US$4,408.00m in 2024.
  • Looking at the per person revenues, in Japan, each individual generates approximately US$7.68 units of revenue in 2024.
  • In Japan, there is a growing trend towards natural and herbal digestive remedies in the OTC Pharmaceuticals market.

Key regions: Brazil, India, United Kingdom, Germany, China

Region comparison

Analyst Opinion

The Digestives & Intestinal Remedies market in Japan is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences:
Customers in Japan have become more health-conscious in recent years, leading to an increased demand for digestive and intestinal remedies. This shift in preferences is driven by a desire to maintain overall well-being and prevent digestive issues. As a result, there is a growing demand for natural and organic products that promote digestive health. Consumers are also seeking products that are easy to consume and have minimal side effects.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market in Japan is the rising popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They are commonly found in fermented foods and supplements. The demand for probiotics is driven by the increasing awareness of their positive effects on gut health and overall well-being. Manufacturers are responding to this trend by introducing a wide range of probiotic products, including yogurts, drinks, and supplements.Another trend in the market is the growing interest in traditional Japanese remedies. Traditional remedies, such as herbal teas and medicinal plants, have been used for centuries in Japan to treat digestive issues. These remedies are gaining popularity among consumers who prefer natural and traditional approaches to healthcare. Manufacturers are capitalizing on this trend by incorporating traditional ingredients into their products and highlighting their natural and traditional origins.

Local special circumstances:
Japan has a rapidly aging population, which has implications for the Digestives & Intestinal Remedies market. As people age, they are more prone to digestive issues, such as indigestion and constipation. This demographic trend is driving the demand for digestive and intestinal remedies in Japan. Manufacturers are targeting this segment of the population by developing products that address the specific needs of older consumers, such as easy-to-swallow tablets and products that promote regular bowel movements.

Underlying macroeconomic factors:
The growing Digestives & Intestinal Remedies market in Japan is also influenced by underlying macroeconomic factors. The country has a well-developed healthcare system and a high level of disposable income, which enables consumers to afford healthcare products. Additionally, Japan has a strong pharmaceutical industry and a culture of innovation, which encourages the development of new products and technologies in the healthcare sector. These factors contribute to the growth of the Digestives & Intestinal Remedies market in Japan.In conclusion, the Digestives & Intestinal Remedies market in Japan is experiencing growth due to changing customer preferences, emerging trends, and local special circumstances. Customers in Japan are increasingly health-conscious and prefer natural and organic products. The market is witnessing a rise in the popularity of probiotics and traditional Japanese remedies. The aging population in Japan is also driving the demand for digestive and intestinal remedies. Overall, the market is supported by Japan's well-developed healthcare system, high disposable income, and culture of innovation.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.


  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)